LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001777938

Ryan Spencer

24 transactions in 2 companies, from December 23, 2025 to February 10, 2026.

Transactions
242 companies
Bought · P
$0open market
Sold · S
$0open market
Net
+$0net buying

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
DYNAVAX TECHNOLOGIES CORPDVAX21——
Cidara Therapeutics, Inc.CDTX3——

All transactions

24 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D90,667——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D55,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D225,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D231,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D280,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D350,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D250,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D130,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D400,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVFeb 10D50,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEOFeb 10D136,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEOFeb 10A136,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEOFeb 10D165,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEOFeb 10A165,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEOFeb 10U379,620——
Cidara Therapeutics, Inc.CDTXRyan SpencerDirDERIVJan 7D11,100——
Cidara Therapeutics, Inc.CDTXRyan SpencerDirDERIVJan 7D2,125——
Cidara Therapeutics, Inc.CDTXRyan SpencerDirDERIVJan 7D4,250——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVDec 23M45,333——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODERIVDec 23M55,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODec 24F138,168$15.38$2.1M
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODec 23M45,333——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODec 23M55,000——
DYNAVAX TECHNOLOGIES CORPDVAXRyan SpencerCEODec 23A156,250——